These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31229666)

  • 61. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
    Forsberg O; Carlsson B; Tötterman TH; Essand M
    Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
    Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
    J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.
    McLaughlin-Taylor E; Pande H; Forman SJ; Tanamachi B; Li CR; Zaia JA; Greenberg PD; Riddell SR
    J Med Virol; 1994 May; 43(1):103-10. PubMed ID: 8083644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
    Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function.
    Samuel ER; Newton K; Mackinnon S; Lowdell MW
    Br J Haematol; 2013 Jan; 160(1):87-100. PubMed ID: 23043413
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.
    Meehan KR; Wu J; Webber SM; Barber A; Szczepiorkowski ZM; Sentman C
    Cytotherapy; 2008; 10(1):30-7. PubMed ID: 18202972
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.
    Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D
    J Immunother; 2012 Sep; 35(7):579-86. PubMed ID: 22892454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.
    Lacey SF; Martinez J; Gallez-Hawkins G; Thao L; Longmate J; Haq W; Spielberger R; Forman SJ; Zaia JA; Diamond DJ
    J Infect Dis; 2005 Mar; 191(6):977-84. PubMed ID: 15717275
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus.
    Bitmansour AD; Waldrop SL; Pitcher CJ; Khatamzas E; Kern F; Maino VC; Picker LJ
    J Immunol; 2001 Aug; 167(3):1151-63. PubMed ID: 11466329
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.
    Khan N; Shariff N; Cobbold M; Bruton R; Ainsworth JA; Sinclair AJ; Nayak L; Moss PA
    J Immunol; 2002 Aug; 169(4):1984-92. PubMed ID: 12165524
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects.
    Vescovini R; Biasini C; Fagnoni FF; Telera AR; Zanlari L; Pedrazzoni M; Bucci L; Monti D; Medici MC; Chezzi C; Franceschi C; Sansoni P
    J Immunol; 2007 Sep; 179(6):4283-91. PubMed ID: 17785869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT.
    Pourgheysari B; Piper KP; McLarnon A; Arrazi J; Bruton R; Clark F; Cook M; Mahendra P; Craddock C; Moss PA
    Bone Marrow Transplant; 2009 Jun; 43(11):853-61. PubMed ID: 19104497
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
    Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
    Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.
    La Rosa C; Longmate J; Lingaraju CR; Zhou Q; Kaltcheva T; Hardwick N; Aldoss I; Nakamura R; Diamond DJ
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):771-784. PubMed ID: 30562587
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants.
    Engstrand M; Tournay C; Peyrat MA; Eriksson BM; Wadström J; Wirgart BZ; Romagné F; Bonneville M; Tötterman TH; Korsgren O
    Transplantation; 2000 Jun; 69(11):2243-50. PubMed ID: 10868621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy.
    Watanabe K; Suzuki S; Kamei M; Toji S; Kawase T; Takahashi T; Kuzushima K; Akatsuka Y
    Int J Hematol; 2008 Oct; 88(3):311-320. PubMed ID: 18677654
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use.
    Gotti E; Tettamanti S; Zaninelli S; Cuofano C; Cattaneo I; Rotiroti MC; Cribioli S; Alzani R; Rambaldi A; Introna M; Golay J
    Cytotherapy; 2022 Mar; 24(3):334-343. PubMed ID: 35063359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.